Table 2.
DOK1 expression was associated with the prognosis of different cancers in PrognoScan.
| Data set | Cancer Type | Endpoint | COX p-value | HR | 95% CI (low -high) |
|---|---|---|---|---|---|
| GSE12417-GPL570 | Blood cancer (AML) | OS | 0.005908 | 3.09 | 1.38–6.91 |
| GSE5122 | Blood cancer (AML) | OS | 0.049976 | 1.41 | 1.00–1.99 |
| MGH-glioma | Brain cancer (Glioma) | OS | 0.026259 | 1.87 | 1.08–3.24 |
| GSE4412-GPL96 | Brain cancer (Glioma) | OS | 0.004309 | 5.61 | 1.72–18.31 |
| GES12276 | Breast cancer | RFS | 0.000316 | 0.70 | 0.58–0.85 |
| GSE11121 | Breast cancer | DMFS | 0.000363 | 0.38 | 0.23–0.65 |
| GSE1378 | Breast cancer | RFS | 0.048402 | 0.71 | 0.51–1.00 |
| GSE1456-GPL96 | Breast cancer | DSS | 0.015867 | 0.57 | 0.37–0.90 |
| GSE1456-GPL96 | Breast cancer | RFS | 0.011870 | 0.30 | 0.12–0.77 |
| GSE7390 | Breast cancer | OS | 0.040569 | 0.73 | 0.54–0.99 |
| GES11595 | Esophagus cancer | OS | 0.003069 | 0.25 | 0.10–0.62 |
| Jacob-00182-HLM | Lung cancer (Adenocarcinoma) | OS | 0.006034 | 0.27 | 0.11–0.69 |
| Jacob-00182-MSK | Lung cancer (Adenocarcinoma) | OS | 0.028547 | 0.20 | 0.05–0.84 |
| GSE13213 | Lung cancer (Adenocarcinoma) | OS | 0.028070 | 0.69 | 0.49–0.96 |
| GSE3120 | Lung cancer (Adenocarcinoma) | RFS | 0.012020 | 5.07 | 1.43–18.02 |
| Jacob-00182-UM | Lung cancer (Adenocarcinoma) | OS | 0.032661 | 0.47 | 0.23–0.94 |
| GSE9891 | Ovarian cancer | OS | 0.036597 | 0.58 | 0.34–0.97 |
| GSE26712 | Ovarian cancer | DFS | 0.003239 | 0.59 | 0.41–0.84 |
| GSE26712 | Ovarian cancer | OS | 0.003871 | 0.57 | 0.39–0.83 |
| GSE19234 | Skin cancer (Melanoma) | OS | 0.041078 | 0.16 | 0.03–0.93 |
Annotation: OS, overall survival; RFS, relapse free survival; DSS, disease specific survival; DFS, Disease Free Survival; DMFS, Distant Metastasis Free Survival.